Clinical TrialsSearch results
Number of results: 854
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants
- masseter muscle prominence
- Yajima Yoko
- 2023-11-21
Not yet recruiting
- Multidisciplinary Approach after Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure
- Atrial fibrillation
- Yagishita Atsuhiko
- 2023-12-06
Recruiting
- Utility of Intrinsic Antitachycardia Pacing in Ventricular Tachycardia
- Ventricular tachycardia
- Yagishita Atsuhiko
- 2023-04-18
Recruiting
- A Phase 2/3, Open-label, Historical-controlled, Single-arm, Multicenter Studyto Evaluate the Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety ofRavulizumab in Children and Adolescents With Aquaporin-4 Antibody Positive(AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Neuromyelitis Optica Spectrum Disorder
- Wuebbenhorst Hiroaki
- 2022-08-09
Other
- A combination phase I/II study of topotecan with carboplatin for relapsed small cell lung cancer
- relapsed small cell lung cancer
- West Japan Oncology Group
- 2005-09-07
Other
- A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimen
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-13
Other
- A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Lung Cancer Evaluation of TS-1 Study
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-10-18
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11